Canada markets open in 4 hours 47 minutes

  • S&P/TSX

    19,203.70
    +2.40 (+0.01%)
     

  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     

  • DOW

    33,677.27
    -68.13 (-0.20%)
     

  • CAD/USD

    0.7974
    -0.0007 (-0.09%)
     

  • CRUDE OIL

    60.98
    +0.80 (+1.33%)
     

  • BTC-CAD

    80,970.39
    +4,086.38 (+5.31%)
     

  • CMC Crypto 200

    1,396.67
    +102.68 (+7.94%)
     

  • GOLD FUTURES

    1,746.90
    -0.70 (-0.04%)
     

  • RUSSELL 2000

    2,228.92
    -4.86 (-0.22%)
     

  • 10-Yr Bond

    1.6230
    0.0000 (0.00%)
     

  • NASDAQ futures

    13,998.00
    +22.25 (+0.16%)
     

  • VOLATILITY

    16.70
    -0.21 (-1.24%)
     

  • FTSE

    6,896.62
    +6.13 (+0.09%)
     

  • NIKKEI 225

    29,620.99
    +82.29 (+0.28%)
     

  • CAD/EUR

    0.6658
    -0.0015 (-0.22%)
     

Michelin Plans to Make 100 Percent Sustainable Tyres by 2050; Reveals Video to Highlight Challenges

News18
·1 min read

Tyre-maker Michelin has announced that all of its tyres will be made from sustainable materials by 2050. To achieve this, Michelin plans to draw on the expertise of its R&D department, while also forming partnerships with innovative startups. The idea of sustainable tyres has been gaining ground for several years at Michelin, with projects such as the firm’s VISION concept tyre, an airless, connected, rechargeable and entirely sustainable solution introduced in 2017. Currently, just 30% of the components used in manufacturing Michelin tyres are made from natural, recycled or otherwise sustainable raw materials.

And the challenge of achieving 100% sustainability is considerable, since a tyre comprises more than 200 ingredients, from natural rubber and synthetic rubber to metal, fibers, carbon black and silica. It is the Michelin research and development department that will be responsible for finding the magic recipe for making the firm’s tyres 100% sustainable in the next 30 years, while continuing to ensure comfort and safety.

By joining forces with specialist startups, Michelin also soon hopes to start recycling polystyrene and recovering carbon black or pyrolysis oil from used tires. The firm recently partnered with the Swedish company, Enviro to build a first tire recycling plant in Chile, coming in 2023.

Enviro has patented technology for recovering carbon black, pyrolysis oil, steel, gas and other new, high-quality reusable materials from scrap tires. Eventually, the aim is to recycle each end-of-life tyre in its entirety. Located near Antofagasta in Chile, the plant should be able to recycle around 30,000 tons of tyres per year.

Latest Stories

  • Queen returns to royal duties after death of Prince Philip

    Queen Elizabeth II has returned to royal duties, four days after the death of her husband, Prince Philip. The 94-year-old British monarch attended a retirement ceremony for a senior royal official on Tuesday, according to the Court Circular, the official record of royal engagements. The royal family is observing two weeks of mourning for Philip, who died Friday at the age of 99.

  • LVMH shares hit record high after strong sales figures

    LVMH's shares rose to record highs on Wednesday after the world's biggest luxury goods company posted sales figures that showed it had bounced back far more quickly than expected in early 2021. LVMH shares were up by 2.7% in early session trading, hitting new record levels, and also lifting up the shares of rival luxury goods companies such as Kering and Hermes. Late on Tuesday, LVMH posted first-quarter revenues that even exceeded 2019 levels, before the pandemic.

  • Egypt Seizes Suez Ship ‘Ever Given’ Pending $900 Million Compensation

    (Bloomberg) -- Egypt seized a giant container vessel that blocked the Suez Canal last month as talks continued over the more than $900 million in compensation sought by authorities.A court in the city of Ismailia granted a seizure request regarding the Ever Given vessel at the behest of the Suez Canal Authority, state-run Ahram Gate reported Tuesday on its website.Egypt’s move underscores the legal complications following the container vessel’s grounding on March 23, which closed the canal for almost a week and roiled shipping markets. Logjams are expected to continue in the coming weeks at major ports such as Singapore and Rotterdam because of disruptions to schedules, according to supply-chain data provider project44.The Suez Canal Authority’s chief executive officer, Osama Rabie, told an Egyptian TV channel late Tuesday that negotiations with the ship’s owners and insurers were taking longer than anticipated, especially given the vessel and its containers were undamaged.The ship’s insurer for third-party losses, the U.K. P&I Club, said in a statement on Tuesday that the Ever Given’s owner -- Japan-based Shoei Kisen Kaisha Ltd. -- received a claim for $916 million.“Despite the magnitude of the claim which was largely unsupported, the owners and their insurers have been negotiating in good faith with the SCA,” the statement said. “On 12 April, a carefully considered and generous offer was made to the SCA to settle their claim. We are disappointed by the SCA’s subsequent decision to arrest the vessel today.”The U.K. P&I Club also said it was “disappointed at comments by the SCA that the ship will be held in Egypt until compensation is paid, and that her crew will be unable to leave the vessel during this time.”Loss of FeesThe SCA has said compensation is needed to cover losses of transit fees, damage to the waterway during the dredging and salvage efforts, and the cost of equipment and labor. It has calculated that it missed out on about $15 million of transit fees each day.The U.K. P&I Club said the claim included a $300 million salvage bonus and another $300 million for loss of reputation.“The claim presented by the SCA also does not include the professional salvor’s claim for their salvage services which owners and their hull underwriters expect to receive separately,” the U.K. P&I Club said. “The grounding resulted in no pollution and no reported injuries. The vessel was re-floated after six days and the Suez Canal promptly resumed their commercial operations.”Negotiations will continue, it said. The SCA didn’t respond to requests for comment.The SCA’S CEO, speaking to Egypt’s Mehwar TV channel, said the owners and insurers “didn’t say when or what they’ll pay” and hadn’t mentioned specific figures.“We sent them a figure, they said we want a breakdown,” Rabie said. “We sent the breakdown, they said we want a detailed one. We sent them a detailed breakdown, but so far nothing.”Rabie stressed again that seizing the Ever Given is a legal procedure that would be lifted as soon as there’s payment.A spokesman for Shoei Kisen Kaisha declined to comment on compensation while discussions with the SCA are underway. The company said the crew is still on board the ship, which is now in the Great Bitter Lake, about halfway along the canal.The charterer, Taiwan’s Evergreen Marine Corp., said in an email it hadn’t received any information from the ship’s owner about a court order.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • On Memorial Day, Israel mourns, reflects on vets' trauma

    Israel marked its national Memorial Day for fallen soldiers on Wednesday, in a year when national attention has been focused on the plight of veterans suffering from psychological trauma. Memorial Day is the most solemn day on Israel's national calendar. Israel has fought half a dozen wars with neighboring Arab countries, battled two Palestinian uprisings and endured scores of deadly militant attacks since its establishment in 1948.

  • Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

    Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceuticals Contract Manufacturing Market Report 2020-2030" - https://www.reportlinker.com/p06058471/?utm_source=GNW Market Dynamics • Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs • Increasing outsourcing of biopharmaceuticals-related manufacturing activities • Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market • Increasing productivity and efficiency of biopharmaceuticals manufacturing processes • Uptake of single-use production systems by the biopharmaceutical manufacturing industry • Asia emerging as hot destination for biopharmaceutical manufacturing • Increasing confidence of pharmaceutical industry in CDMOs capabilities • High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs • Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers • Increasing shortage of skilled workforce in the biopharmaceutical industry • Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth • Complicated and stringent regulatory requirements hinder market growth Market Segmentation 2020-2030 Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis. Service • Process Development – Downstream – Upstream • Fill & Finish Operations • Analytical & Quality Control Studies • Packaging Product • Biologics – Monoclonal Antibodies (MAbs) – Recombinant Proteins – Vaccines – Insulin • Biosimilars Regional Breakdown Focused regional forecasts and analysis explore the future opportunities: • North America – U.S. – Canada • Europe – UK – France – Germany – Russia – Rest of Europe • Asia-Pacific – China – Japan – India – Southeast Asia – Rest of Asia Pacific • Latin America – Brazil – Argentina – Rest of Latin America • Middle East & Africa – GCC – South Africa – Rest of Middle EastRead the full report: https://www.reportlinker.com/p06058471/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Outlook on the Semiconductor Etch and Deposition Global Market to 2026 - Insights, COVID-19 Impact, Competition and Forecasts

    Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Semiconductor Etch and Deposition Market - Analysis By Equipment Type, Application, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering. The Global Semiconductor Etch and Deposition Market, valued at USD 30278.72 Million in the year 2020 has been witnessing unprecedented growth in the last few years on the back of Increasing growth of semiconductor equipment industry, Increasing in investment in wafer industry is one of the major reasons behind the increasing Semiconductor Etch and Deposition market globally. Additionally, Growing demand from consumer electronics, Increasing demand for silicon wafer will drive the Semiconductor Etch and Deposition market value in the near future.Among the Equipment Type in the Semiconductor Etch and Deposition market (Etching Equipment and Deposition Equipment), Etching Equipment is large segment globally and is expected to grow steadily in the forecast period. The need of etching in semiconductor devices will drive the market.Among the Application of the Semiconductor Etch and Deposition market (Logic and Memory, MEMS, Power Device and Others), Logic and Memory holds large share in market globally and is expected to keep growing in the forecast period. It is one of the largest application of Semiconductor Etch and Deposition due to the high demand of logic and memory devices in electronic devices, the rising adoption of IoT and digitalization will keep driving the market in future.The APAC is expected to lead the global market throughout the forecasted period. The adoption of new technologies and increasing demand of consumer electronics in APAC countries and presence of leading Semiconductor Etch and Deposition companies, is expected to infuse market growth tremendously.Scope of the Report The report analyses the Semiconductor Etch and Deposition market by Value.The report analyses the Semiconductor Etch and Deposition Market by the Equipment Type (Etching Equipment and Deposition Equipment).The report analyses the Semiconductor Etch and Deposition Market by the Application (Logic and Memory, MEMS, Power Device and Others)The Global Semiconductor Etch and Deposition Market has been analysed By Region (Americas, Europe and Asia Pacific) and By Country (United States, Brazil, Canada, Germany, France, United Kingdom, China, Japan, South Korea and Taiwan).The attractiveness of the market has been presented by region, by Equipment Type and By Appliation. Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include LAM Research, Tokyo Electron Limited, ASM International, Applied Materials, Plasma-Therm, Panasonic Corporation, Hitachi High-Tech Corporation, KLA Corporation, Oxford Instruments and ULVACThe report analyses the impact of Covid-19 on Semiconductor Etch and Deposition market.The report presents the analysis of Semiconductor Etch and Deposition market for the historical period of 2016-2020 and the forecast period of 2021-2026. Key Topics Covered: 1. Research Methodology and Executive Summary1.1 Research Methodology1.2 Executive Summary2. Strategic Recommendations3. Global Semiconductor Etch and Deposition Market: Product Outlook4. Global Semiconductor Etch and Deposition Market: Sizing and Forecast4.1 Market Size, By Value, Year 2016-20264.2 Impact of COVID-19 on Global Semiconductor Etch and Deposition Market4.3 Global Economic and Industrial Statistics5. Global Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application5.1 Competitive Scenario of Semiconductor Etch and Deposition Market: By Equipment Type5.1.1 Etching Equipment n Market Size and Forecast (2016-2026)5.1.2 Deposition Equipment n Market Size and Forecast (2016-2026)5.2 Competitive Scenario of Semiconductor Etch and Deposition Market: By Application5.2.1 Logic and Memory n Market Size and Forecast (2016-2026)5.2.2 MEMS n Market Size and Forecast (2016-2026)5.2.3 Power Device n Market Size and Forecast (2016-2026)5.2.4 Others n Market Size and Forecast (2016-2026)6. Global Semiconductor Etch and Deposition Market: Regional Analysis6.1 Competitive Scenario of Semiconductor Etch and Deposition Market: By Region7. America Semiconductor Etch and Deposition Market: Segmentation by Equipment Type, By Application (2016-2026)7.1 America Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value7.2 Americas Economic and Industrial Statistics7.3 Americas Semiconductor Etch and Deposition Market- Prominent Companies7.4 Market Segmentation by Equipment Type (Etching Equipment and Deposition Equipment)7.5 Market Segmentation by Application (Logic and Memory, MEMS, Power Device and Others)7.6 America Semiconductor Etch and Deposition Market: Country Analysis7.7 Market Opportunity Chart of America Semiconductor Etch and Deposition Market - By Country, By Value, 20267.8 Competitive Scenario of America Semiconductor Etch and Deposition Market: By Country7.9 United States Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value7.10 United States Economic and Industrial Statistics7.11 United States Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application7.12 Canada Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value7.13 Canada Economic and Industrial Statistics7.14 Canada Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application7.15 Brazil Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value7.16 Brazil Economic and Industrial Statistics7.17 Brazil Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application8. Europe Semiconductor Etch and Deposition Market: Segmentation by Equipment Type, By Application (2016-2026)8.1 Europe Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value8.2 Europe Economic and Industrial Statistics8.3 Europe Semiconductor Etch and Deposition Marketn Prominent Companies8.4 Market Segmentation by Equipment Type (Etching Equipment and Deposition Equipment)8.5 Market Segmentation by Application (Logic and Memory, MEMS, Power Device and Others)8.6 Europe Semiconductor Etch and Deposition Market: Country Analysis8.7 Market Opportunity Chart of Europe Semiconductor Etch and Deposition Market - By Country, By Value, 20268.8 Competitive Scenario of Europe Semiconductor Etch and Deposition Market: By Country8.9 Germany Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value8.10 Germany Economic and Industrial Statistics8.11 Germany Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application8.12 United Kingdom Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value8.13 United Kingdom Economic and Industrial Statistics8.14 United Kingdom Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application8.15 France Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value8.16 France Economic and Industrial Statistics8.17 France Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application9. Asia Pacific Semiconductor Etch and Deposition Market: Segmentation by Equipment Type, By Application (2016-2026)9.1 Asia Pacific Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value9.2 Asia Pacific Economic and Industrial Statistics9.3 Asia Pacific Semiconductor Etch and Deposition Market - Prominent Companies9.4 Market Segmentation by Equipment Type (Etching Equipment and Deposition Equipment)9.5 Market Segmentation by Application (Logic and Memory, MEMS, Power Device and Others)9.6 Asia Pacific Semiconductor Etch and Deposition Market: Country Analysis9.7 Market Opportunity Chart of Asia Pacific Semiconductor Etch and Deposition Market - By Country, By Value, 20269.8 Competitive Scenario of Asia Pacific Semiconductor Etch and Deposition Market: By Country9.9 China Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value9.10 China Economic and Industrial Statistics9.11 China Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application9.12 Japan Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value9.13 Japan Economic and Industrial Statistics9.14 Japan Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application9.15 South Korea Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value9.16 South Korea Economic and Industrial Statistics9.17 South Korea Semiconductor Etch and Deposition Market Segmentation by Equipment Type, By Application9.18 Taiwan Semiconductor Etch and Deposition Market: Size and Forecast (2016-2026), By Value9.19 Taiwan Economic and Industrial Statistics9.20 Taiwan Semiconductor Etch and Deposition Market Segmentation - By Equipment Type, By Application10. Global Semiconductor Etch and Deposition Market Dynamics10.1 Drivers10.2 Restraints10.3 Trends11. Market Attractiveness11.1 Market Attractiveness Chart of Semiconductor Etch and Deposition Market - By Equipment Type, 202611.2 Market Attractiveness Chart of Semiconductor Etch and Deposition Market - By Application, 202611.3 Market Attractiveness Chart of Semiconductor Etch and Deposition Market - by Region, 202612. Competitive Landscape12.1 Mergers and Acquisitions12.2 Market Share Analysis13. Company Analysis13.1 Lam Research13.2 Tokyo Electron Limited13.3 Applied Materials13.4 Plasma-Therm13.5 ASM International13.6 Panasonic Corporation13.7 Hitachi High-Tech Corporation13.8 KLA Corporation13.9 Oxford Instruments13.10 ULVACFor more information about this report visit https://www.researchandmarkets.com/r/9i1x7e CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Disclosure of the number of shares forming the capital and the number of voting rights as of 31 03 2021

    DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 MARS 2021 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social221 819 430Nombre de droits de vote théoriques265 295 364Nombre de droits de vote exerçables265 156 301 Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MARCH 2021 Total number of shares221,819,430Theoretical number of voting rights265,295,364Number of exercisable voting rights265,156,301 This disclosure is on Elis web site www.elis.com Contacts Nicolas Buron, Investor Relations Director - Phone: +33 1 75 49 98 30 - nicolas.buron@elis.com Attachment Disclosure of the number of shares forming the capital and the number of voting rights as of 31 03 2021

  • Watch: Teaser of Unnikrishnan B's Aaraattu, starring Mohanlal, Shraddha Srinath

    Aaraattu is scheduled to release on 12 August on the occasion of Onam

  • Indian Women’s Rights Mattered to Ambedkar. Here’s What He Enabled

    Ambedkar paved the way for Indian women to legally vote, divorce, and own property. He was indeed a feminist.

  • Taylor Swift's appearance on 'The Late Show With Stephen Colbert' has fans scrambling for answers

    While exactly what she was trying to tell them is up for debate, many Taylor Swift fans agree she was trying to tell them something.

  • Sterling recovers ground, hits one-week high vs. dollar

    Sterling hit a one-week high against the dollar on Wednesday, recovering some ground after a brief dip the previous day following news the Bank of England's chief economist resigned. Haldane was widely seen as one of the more hawkish figures at the central bank, and had been the most upbeat member of the BoE's Monetary Policy Committee on prospects for a sharp economic recovery from the COVID-19 pandemic. By 0802 GMT, the pound was 0.2% higher on the day at $1.3786, having hit a one-week high of $1.38 against the dollar.

  • Iran's Rouhani says 60% enrichment is an answer to attack at Natanz site

    Iran's move to enrich uranium up to 60% purity is a response to the sabotage at its key nuclear facility, President Hassan Rouhani said on Wednesday, adding the Islamic Republic had no intention of building a nuclear weapon. After an explosion at its Natanz uranium enrichment site on Sunday blamed by Tehran on arch-foe Israel, Iran said it would begin enriching uranium at 60%, a move bringing the fissile material closer to levels suitable for a bomb.

  • Biopharmaceuticals Excipients Market 2020-2030

    Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others. The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceuticals Excipients Market 2020-2030" - https://www.reportlinker.com/p06058472/?utm_source=GNW 2%. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 162-page report you will receive 85 charts– all unavailable elsewhere. The 162-page report provides clear detailed insight into the biopharmaceuticals excipients market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • Biopharmaceuticals excipients market forecasts to 2030 • This report also breaks down the revenue forecast for the global pharmaceutical excipient market by product type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Biopharmaceutical Excipients) • Solubilizers & Surfactants/Emulsifiers: • Triglycerides • Esters • Others • This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by Polyols: • Mannitol • Sorbitol • Others • This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by carbohydrates: • Sucrose • Dextrose • Starch • Others • This report provides individual revenue forecasts to 2030 for these regional and national markets: • North America: US and Canada • Europe: UK, France, Germany, Spain, Italy, Rest of Europe • APAC: China, India, Australia, Indonesia, South Korea, Rest of APAC • MEA • RoW Each region is further broken down by product type • Our study gives a SWOT & PEST Analysis • Our study discusses the selected leading companies that are the major players in the biopharmaceuticals excipients market: • ABITEC Corp • Signet Chemical Corporation • Roquette Freres SA • Sigachi Industries • MEGGLE AG • & Other Companies This study is intended for anyone requiring commercial analyses for the biopharmaceuticals excipients market. You find data, trends, and predictions.Read the full report: https://www.reportlinker.com/p06058472/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Chinese man kidnapped and killed in elaborate body swap scheme

    The victim was used as a replacement for another corpse, whose family wanted to avoid a burial ban.

  • The Latest: Spain keeps immunization goal despite J&J delay

    MADRID — Spain’s prime minister says his government is maintaining its goal of immunizing 70% of the nation’s adult population, some 33 million people, by the end of the summer despite the delay in the European rollout of the Johnson & Johnson vaccine. Spain was expecting to receive 300,000 doses of the Janssen vaccine on Wednesday, the first delivery of the jab produced by Johnson & Johnson. The country wants to prioritize people aged between 70 and 79 to receive the single-dose vaccine. But those plans had to be put on hold after the pharmaceutical company delayed delivery of the vaccine to European countries following the decision by the U.S. Food and Drug Administration to pause the shots in the United States to investigate possible links to very rare blood clots. The hold up comes after various delays in shipments of other vaccines and a similar blood clot scare with the AstraZeneca vaccine that led Spain to limit it to people over 60 years old. Prime Minister Pedro Sánchez, however, told Spain’s Parliament on Wednesday that “the pace of vaccination is going to accelerate in the month of April and (…) we will meet out goal.” ___ THE VIRUS OUTBREAK: — US recommends ‘pause’ for J&J shots in blow to vaccine drive — Biden says pause on J&J shots shows gov’t putting safety 1st — EXPLAINER: What’s known about COVID vaccines and rare clots — The postponed Tokyo Olympics open in 100 days, but nothing is certain these days — California is lagging in reopening schools, and parents are finding some options unacceptable — Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine ___ HERE’S WHAT ELSE IS HAPPENING: BERLIN — German health authorities are recommending that people younger than 60 who have already received one shot of the AstraZeneca vaccine use a different vaccine for their second dose over concerns of blood clots. The Health Ministry said Wednesday that it was recommending that people in that category receive as their second shot either the Pfizer/BioNTech or Moderna vaccination, both of which were developed using a different process. It says, however, that in individual cases younger people wanting a second AstraZeneca shot can get one so long as they have a careful medical risk assessment. That also applies to high-risk people under the age of 60 still awaiting their primary vaccination. The reports of rare blood clots in some people who’ve received the vaccine prompted Germany and several other countries in the 27-nation European Union to limit the AstraZeneca shots to older age groups, who are more at risk from serious illness when infected with COVID-19. ____ CANBERRA, Australia — Australia’s trade minister will fly to Europe to argue against export restrictions on COVID-19 vaccines as the nation attempts to accelerate its inoculation rollout. Trade Minister Dan Tehan leaves on Thursday for Geneva, Berlin, Brussels, Paris and London with vaccine supply added to a post-Brexit trade deal agenda. “The first idea I’ll be bringing to the table is that export restrictions aren’t the way to go,” Tehan told Australian Broadcasting Corp. on Wednesday. Deliveries of the AstraZeneca vaccine to Australia were 3 million doses behind schedule, he said. Australia is rethinking its vaccine rollout after the nation's health authorities advised last week that Pfizer was now the preferred option for people younger than 50 because of a potential risk of rare blood clots linked to the AstraZeneca shot. The government also abandoned its target of delivering at least one dose of either vaccine to all eligible adults among a population of 26 million by October. But Prime Minister Scott Morrison said on Wednesday offering all Australian adults at least one vaccine dose by the end of 2021 was a possibility if international supply lines remained open. The European Union last month blocked a shipment of more than 250,000 AstraZeneca doses from Italy to Australia because the need for them was not considered great enough in a country largely successful in containing the coronavirus. ___ SEOUL, South Korea — South Korea has recorded its highest daily jump in new COVID-19 infections in about three months, as officials urge the public to maintain vigilance. The Korea Disease Control and Prevention Agency said Wednesday it’s confirmed 731 new cases over the past 24 hours. They brought the country’s total to 111,419 with 1,782 deaths. The spike comes amid criticism of a slow vaccine rollout while people are increasingly venturing outdoors to take advantage of good weather. Senior health official Yoon Taeho says an increased mobility last weekend was proof that South Korea’s public vigilance has loosened, and that elevating social distancing rules will be discussed in the next few days. ___ HELENA, Mont. — Montana Gov. Greg Gianforte has issued an executive order banning the development or use of vaccine passports in Montana. Vaccine passports are documents that could be used to verify coronavirus immunization status and allow inoculated people to more freely travel, shop and dine. The move by Gianforte on Tuesday comes as vaccine passports have drawn criticism as a heavy-handed intrusion into personal freedom and private health choices. Gianforte says in a statement that he encourages all Montana residents to get vaccinated but that it is “entirely voluntary.” Vaccine passports have been implemented in New York but the White House has said there will not be any federal vaccine passport program. ___ HOLLAND, Mich. — A western Michigan restaurant owner who spent four nights in jail for violating coronavirus-related orders is firing back weeks later with a demand that $15,000 in fines be refunded and contempt findings dropped. An attorney for Marlena Pavlos-Hackney said her rights were violated during a contentious court hearing on March 19. State regulators yanked Pavlos-Hackney’s food license in January for serving indoor diners and breaking other rules related to preventing the spread of COVID-19. But the restaurant, Marlena’s Bistro and Pizzeria in Holland, stayed open in defiance. Pavlos-Hackney refused to turn herself in to face a contempt hearing. She was arrested and spent four nights in jail until authorities were convinced that her restaurant would stay closed. Attorney Robert Baker, who wasn’t hired until Pavlos-Hackney was arrested, said a judge questioned her without recognizing that she had a lawyer. He said there was “no testing of any evidence” or an opportunity to cross-examine or produce witnesses. A message seeking comment was sent to the attorney general’s office. ___ AMSTERDAM — The Dutch government has presented a roadmap for relaxing coronavirus lockdown measures, but caretaker Prime Minister Mark Rutte is stressing that it is still too early to ease restrictions. In a nationally televised press conference Tuesday, Rutte said hospitals in the Netherlands are as crowded with COVID-19 patients now as they were during the first wave of the pandemic last year and that it would be irresponsible to relax the country’s months-long lockdown now. The government had previously said it hoped the first relaxation could have started April 21, but Rutte said that was too soon. Earlier Tuesday, the Dutch public health institute said the number of new coronavirus infections rose 6% over the past week to 51,240, with the largest increase in positive tests recorded among children aged 13-17 years. The increase comes despite the months-long tough lockdown in the Netherlands including a nighttime curfew, closed bars and restaurants and shuttered public institutions like museums and zoos. ___ WASHINGTON — U.S. health insurance customers may receive higher premium rebates than normal later this year partly because insurers had less care to cover after COVID-19 arrived in 2020. Some individual insurance customers could receive premium credits or rebates of nearly $300 on average, according to an analysis of government data from the non-profit Kaiser Family Foundation. The Affordable Care Act requires insurers to give customers refunds or premium credits if they don’t spend certain percentages of the premiums they collect on care and costs related to it. Kaiser’s analysis noted that last year hospitals and other care providers cancelled surgeries and non-essential care early in the pandemic and then during subsequent COVID-19 spikes. Kaiser Vice-President Cynthia Cox said nearly half of customers in the individual market receive these annual rebates. Some people with employer-sponsored coverage also may get rebates that they share with their company. Rebate totals will be finalized later this year. They generally are then delivered by the end of September. The totals will vary by market and depend on factors like whether an insurer has already offered premium breaks to counter the drop in care. ___ WASHINGTON — The nation’s capital city joined a growing list of states in suspending the Johnson & Johnson COVID-19 vaccine that’s become the focus of a federal examination of rare blood clots. District of Columbia health director Dr. LaQuandra Nesbitt says she’s not aware of any cases of dangerous blood clots among the 16,000 Washingtonians who had received the J&J one-dose vaccine before the temporary halt recommended by federal health authorities. “This pause means that the system is working properly,” Nesbitt says. Dr. Anthony Fauci, the nation’s top infectious disease expert, echoed Nesbitt, saying Americans who’ve recently received a Johnson & Johnson COVID-19 vaccine shouldn’t be anxious about the pause. Fauci called it a “testimony to how seriously we take safety.” J&J said in a statement Tuesday it was aware of the reports of blood clots, but that no link to its vaccine had been established. A CDC committee will meet Wednesday to discuss the cases. The FDA has launched an investigation into the cause of the clots and low platelet counts. There have been six reported clots among the 6.8 million shots administered. U.S. health authorities cautioned doctors against using a typical clot treatment, the blood-thinner heparin. “In this setting, administration of heparin may be dangerous and alternative treatments need to be given,” the FDA and CDC say. Washington state, Idaho, California, Alabama, Wisconsin, Colorado, Nevada and Alaska are among the states that have temporarily halted or have recommended pausing the use of the Johnson & Johnson shot amid the investigation. ___ BERLIN — South Africa has suspended giving the Johnson & Johnson vaccine as a “precautionary measure” following the FDA decision in the U.S. to pause the use of the vaccine while rare blood clots are examined. All six cases were in women between ages 18 to 48, including one who died. The unusual clots occurred six to 13 days after vaccination. South Africa has given more than 289,000 shots of the J&J vaccine to the country’s health workers without any reports of blood clots, Health Minister Dr. Zweli Mkhize says. He says South Africa is halting the use of the J&J doses “out of an abundance of caution.” He expects the questions regarding the J&J vaccine should “be cleared within a matter of days.” Recently, the blood clot reports prompted several European Union countries in the 27-nation bloc to limit the AstraZeneca vaccine to older age groups. The Associated Press

  • Virgin Media and O2 merger cleared by competition watchdog

    Virgin Media and O2 merger cleared by competition watchdogThe £31bn 50-50 joint venture will create new ‘national champion’ to challenge BT O2 has 34 million mobile customers, while Virgin Media has 5.3 million broadband, pay-TV and mobile users. Photograph: Andre M Chang/Zuma Wire/Rex/Shutterstock

  • Global Virtual Events Market Report 2021-2025 Featuring Zoom, Adobe, Avaya, Aventri, Cisco Systems, Cvent, Huawei, IBM, Microsoft, Ungerboeck

    Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Virtual Events Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Global Virtual Events Market 2021-2025The virtual events market is poised to grow by $269.20 bn during 2021-2025 progressing at a CAGR of 33% during the forecast period. The market is driven by the rise in number of corporate events and increasing need to improve competitive responsiveness. The report on virtual events market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The virtual events market analysis includes application segment and geographical landscapes. This study identifies the growing prominence of social networking sites as one of the prime reasons driving the virtual events market growth during the next few years. The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading virtual events market vendors that include Adobe Inc., Avaya Holdings Corp., Aventri Inc., Cisco Systems Inc., Cvent Inc., Huawei Investment & Holding Co. Ltd., International Business Machines Corp., Microsoft Corp., Ungerboeck, and Zoom Video Communications Inc.. Also, the virtual events market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.Key Topics Covered: Executive Summary Market Overview Market Landscape Market ecosystemMarket characteristicsValue chain analysis Market Sizing Market definitionMarket segment analysisMarket size 2020Market outlook: Forecast for 2020 - 2025 Five Forces Analysis Bargaining power of buyersBargaining power of suppliersThreat of new entrantsThreat of substitutesThreat of rivalryMarket condition Market Segmentation by Application Market segmentsComparison by ApplicationUC and C and video conferencing - Market size and forecast 2020-2025Web conferencing - Market size and forecast 2020-2025Market opportunity by Application Market segmentation by end-users Virtual events for educational institutionsVirtual events for trade showsVirtual events for enterprises Customer landscapeGeographic Landscape Geographic segmentationGeographic comparisonNorth America - Market size and forecast 2020-2025APAC - Market size and forecast 2020-2025Europe - Market size and forecast 2020-2025MEA - Market size and forecast 2020-2025South America - Market size and forecast 2020-2025Key leading countriesMarket opportunity by geographyMarket driversMarket challengesMarket trends Vendor Landscape Vendor landscapeLandscape disruptionCompetitive scenario Vendor Analysis Vendors coveredMarket positioning of vendorsAdobe Inc.Avaya Holdings Corp.Aventri Inc.Cisco Systems Inc.Cvent Inc.Huawei Investment & Holding Co. Ltd.International Business Machines Corp.Microsoft Corp.UngerboeckZoom Video Communications Inc. AppendixFor more information about this report visit https://www.researchandmarkets.com/r/tmbf4b CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Why $30m didn't protect Nigerian pupils after Chibok

    The 2014 student abductions led to a plan backed by the UK but little has come of it seven years on.

  • Tom Hiddleston hints at the effect his Taylor Swift romance had on his approach to career

    Actor says he took ‘a moment of consideration’

  • Kristina Keneally accuses Peter Dutton of cancelling her trip to meet Biloela family

    Kristina Keneally accuses Peter Dutton of cancelling her trip to meet Biloela family. Labor senator says she received Border Force permission for the Christmas Island meeting at 4.50pm but defence minister ‘cancelled the trip’ at 5.12pm